Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.

Latest From David Ridley

How A UK Tech Start-Up Is Disrupting Men’s Health

HBW Insight talks to Numan's chief medical strategy officer Professor Sam Shah about how the UK tech start-up is bringing innovation to the country's men's health category. 

Health OTC Drugs

Australia Continues Down OTC Path For CBD, But Will It Widen Access?

[Link Fixed] Australia's Ministry of Health has provisionally switched CBD from prescription-only to OTC status to widen access in the absence of any safety concerns and to encourage companies to undertake much-needed clinical trials to prove efficacy for CBD in low doses. However, switch expert Natalie Gauld thinks these expensive trials, and therefore approved Australian OTC CBD products, may not be forthcoming.

Health OTC Drugs

‘Swipe Right’ For Rennie – Bayer Partners With Tinder For UK Marketing Campaign

Bayer Consumer Care matches Rennie with popular dating app Tinder in the UK for an innovative new digital marketing campaign, which uses "branded profile cards" to drive engagement with the firm's flagship heartburn brand. 

Health OTC Drugs

Thinking About Entering The EU CBD Market? Some Food For Thought

Consumer health companies are starting to step into the lucrative but fast-changing and complex EU cannabidiol market. But what are the key considerations for firms before making such a move, or if they have already? HBW Insight speaks to CBD regulatory expert Greer Deal. 

Wellness Dietary Supplements

Reverse-Switch Of Stada’s Lemocin On The Agenda Of Germany's Switch Committee

Germany's Expert Committee for Prescription will consider the reverse-switch of tyrothricin – a key ingredient in Stada's recently-acquired Lemocin throat lozenge – to presciption-only status and the Rx-to-OTC switch of soluble fluoride tablets for the oral treatment of osteoporosis.

Health OTC Drugs

Sanofi Expands UK Probiotics Presence With DioraByota

Sanofi Consumer Health Care leans into probiotics trend with another UK probiotic supplement, DioraByota.

Wellness Launches
See All
UsernamePublicRestriction

Register